vs

Side-by-side financial comparison of Clearwater Paper Corp (CLW) and 60 DEGREES PHARMACEUTICALS, INC. (SXTP). Click either name above to swap in a different company.

Clearwater Paper Corp is the larger business by last-quarter revenue ($360.3K vs $303.4K, roughly 1.2× 60 DEGREES PHARMACEUTICALS, INC.). Clearwater Paper Corp runs the higher net margin — -3.6% vs -474.2%, a 470.6% gap on every dollar of revenue. On growth, 60 DEGREES PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (25.6% vs -4.7%). Over the past eight quarters, 60 DEGREES PHARMACEUTICALS, INC.'s revenue compounded faster (69.4% CAGR vs -96.8%).

Clearwater Paper Corporation is an American pulp and paperboard manufacturer. The company was created on December 9, 2008, via a spin-off from Potlatch Corporation and is headquartered in Spokane, Washington.

Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

CLW vs SXTP — Head-to-Head

Bigger by revenue
CLW
CLW
1.2× larger
CLW
$360.3K
$303.4K
SXTP
Growing faster (revenue YoY)
SXTP
SXTP
+30.3% gap
SXTP
25.6%
-4.7%
CLW
Higher net margin
CLW
CLW
470.6% more per $
CLW
-3.6%
-474.2%
SXTP
Faster 2-yr revenue CAGR
SXTP
SXTP
Annualised
SXTP
69.4%
-96.8%
CLW

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLW
CLW
SXTP
SXTP
Revenue
$360.3K
$303.4K
Net Profit
$-12.8K
$-1.4M
Gross Margin
-0.2%
60.2%
Operating Margin
-632.0%
Net Margin
-3.6%
-474.2%
Revenue YoY
-4.7%
25.6%
Net Profit YoY
-103.2%
29.7%
EPS (diluted)
$-8.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLW
CLW
SXTP
SXTP
Q1 26
$360.3K
Q4 25
$386.4M
$303.4K
Q3 25
$399.0M
$437.6K
Q2 25
$391.8M
$100.9K
Q1 25
$378.2M
$163.6K
Q4 24
$387.1M
$241.6K
Q3 24
$393.3M
$135.3K
Q2 24
$344.4M
$125.0K
Net Profit
CLW
CLW
SXTP
SXTP
Q1 26
$-12.8K
Q4 25
$38.3M
$-1.4M
Q3 25
$-53.3M
$-2.3M
Q2 25
$2.7M
$-1.7M
Q1 25
$-6.3M
$-1.9M
Q4 24
$199.1M
$-2.0M
Q3 24
$5.8M
$-2.2M
Q2 24
$-25.8M
$-4.2M
Gross Margin
CLW
CLW
SXTP
SXTP
Q1 26
-0.2%
Q4 25
4.5%
60.2%
Q3 25
4.7%
-22.9%
Q2 25
11.0%
50.4%
Q1 25
9.7%
55.2%
Q4 24
3.8%
51.1%
Q3 24
7.7%
17.4%
Q2 24
-0.6%
28.3%
Operating Margin
CLW
CLW
SXTP
SXTP
Q1 26
Q4 25
1.9%
-632.0%
Q3 25
-13.9%
-531.4%
Q2 25
2.5%
-1590.0%
Q1 25
-1.1%
-1168.4%
Q4 24
-4.0%
-854.7%
Q3 24
-0.3%
-1566.0%
Q2 24
-13.6%
-3351.8%
Net Margin
CLW
CLW
SXTP
SXTP
Q1 26
-3.6%
Q4 25
9.9%
-474.2%
Q3 25
-13.4%
-529.3%
Q2 25
0.7%
-1717.7%
Q1 25
-1.7%
-1147.4%
Q4 24
51.4%
-846.3%
Q3 24
1.5%
-1596.4%
Q2 24
-7.5%
-3339.0%
EPS (diluted)
CLW
CLW
SXTP
SXTP
Q1 26
Q4 25
$2.36
$-8.26
Q3 25
$-3.30
$-0.66
Q2 25
$0.17
$-1.25
Q1 25
$-0.38
$-1.56
Q4 24
$11.87
$-51.96
Q3 24
$0.35
$-2.92
Q2 24
$-1.55
$-21.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLW
CLW
SXTP
SXTP
Cash + ST InvestmentsLiquidity on hand
$36.5M
$2.8M
Total DebtLower is stronger
$361.1M
$150.0K
Stockholders' EquityBook value
$813.8M
$3.5M
Total Assets
$1.6B
$5.4M
Debt / EquityLower = less leverage
0.44×
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLW
CLW
SXTP
SXTP
Q1 26
$36.5M
Q4 25
$30.7M
$2.8M
Q3 25
$34.4M
$4.1M
Q2 25
$46.7M
$2.0M
Q1 25
$44.0M
$3.5M
Q4 24
$79.6M
$3.4M
Q3 24
$35.5M
$5.0M
Q2 24
$39.6M
$1.6M
Total Debt
CLW
CLW
SXTP
SXTP
Q1 26
$361.1M
Q4 25
$346.8M
$150.0K
Q3 25
$337.0M
$150.0K
Q2 25
$330.1M
$150.0K
Q1 25
$150.0K
Q4 24
$283.4M
$150.0K
Q3 24
$1.2B
$150.0K
Q2 24
$1.1B
$150.0K
Stockholders' Equity
CLW
CLW
SXTP
SXTP
Q1 26
$813.8M
Q4 25
$825.3M
$3.5M
Q3 25
$783.0M
$4.4M
Q2 25
$836.8M
$2.4M
Q1 25
$836.6M
$4.1M
Q4 24
$854.6M
$4.0M
Q3 24
$664.6M
$6.0M
Q2 24
$658.6M
$3.0M
Total Assets
CLW
CLW
SXTP
SXTP
Q1 26
$1.6B
Q4 25
$1.6B
$5.4M
Q3 25
$1.6B
$6.7M
Q2 25
$1.6B
$4.2M
Q1 25
$1.6B
$6.0M
Q4 24
$1.7B
$5.8M
Q3 24
$2.5B
$7.4M
Q2 24
$2.5B
$4.3M
Debt / Equity
CLW
CLW
SXTP
SXTP
Q1 26
0.44×
Q4 25
0.42×
0.04×
Q3 25
0.43×
0.03×
Q2 25
0.39×
0.06×
Q1 25
0.04×
Q4 24
0.33×
0.04×
Q3 24
1.73×
0.02×
Q2 24
1.74×
0.05×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLW
CLW
SXTP
SXTP
Operating Cash FlowLast quarter
$-1.7M
Free Cash FlowOCF − Capex
$-1.8M
FCF MarginFCF / Revenue
-584.2%
Capex IntensityCapex / Revenue
26.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLW
CLW
SXTP
SXTP
Q1 26
Q4 25
$5.0M
$-1.7M
Q3 25
$34.0M
$-2.1M
Q2 25
$-28.2M
$-1.5M
Q1 25
$1.5M
$-1.6M
Q4 24
$-35.1M
$-1.6M
Q3 24
$16.2M
$-1.7M
Q2 24
$21.1M
$-1.2M
Free Cash Flow
CLW
CLW
SXTP
SXTP
Q1 26
Q4 25
$-9.9M
$-1.8M
Q3 25
$15.7M
$-2.1M
Q2 25
$-51.1M
$-1.5M
Q1 25
$-31.2M
$-1.6M
Q4 24
$-68.1M
Q3 24
$-30.8M
$-1.7M
Q2 24
$3.0M
FCF Margin
CLW
CLW
SXTP
SXTP
Q1 26
Q4 25
-2.6%
-584.2%
Q3 25
3.9%
-484.2%
Q2 25
-13.0%
-1483.6%
Q1 25
-8.2%
-978.3%
Q4 24
-17.6%
Q3 24
-7.8%
-1252.8%
Q2 24
0.9%
Capex Intensity
CLW
CLW
SXTP
SXTP
Q1 26
Q4 25
3.9%
26.3%
Q3 25
4.6%
2.3%
Q2 25
5.8%
46.9%
Q1 25
8.6%
1.6%
Q4 24
8.5%
Q3 24
12.0%
10.2%
Q2 24
5.3%
Cash Conversion
CLW
CLW
SXTP
SXTP
Q1 26
Q4 25
0.13×
Q3 25
Q2 25
-10.44×
Q1 25
Q4 24
-0.18×
Q3 24
2.79×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons